Rare diseases
Investigational molecules
Locations
4505 Emperor Boulevard Suite 200, 27703-8457, United States
Biocryst Pharmaceuticals Inc. focuses on clinical research in hereditary angioedema, with attention to long-term treatment use, ongoing safety evaluation, and symptom control in affected patients.
Its research activity includes both adult and pediatric populations, reflecting interest in treatment continuity across different age groups.
Biocryst Pharmaceuticals Inc. runs clinical trials in conditions such as Hereditary angioedema, Netherton's syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A Study of BCX17725 Safety and Effects in Healthy People and Patients with Netherton Syndrome
FranceLong-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials
CzechiaStudy on the Safety and Effects of Berotralstat for Children Aged 2 to 12 with Hereditary Angioedema (HAE)
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
